Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Chocolate's Potential Health Benefits – and its Effect on Chronic Fatigue Syndrome Patients

High dose vitamin D3 supplementation lowers inflammatory T cells in multiple sclerosis patients

Essential Oils - How and Where to Use Them

Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

SURVEY: What Is Your Diagnosis?

The Link Between Vitamin C And Optimal Immunity

Liposomes Deliver Optimal Nutrient Absorption

Why Does Your Nose Run When It's Cold Outside?

How Your Mitochondria Influence Your Health

Study suggests that what you eat can influence how you sleep

 
Print Page
Email Article

Trial of Eszopiclone (Lunesta®) for Insomnia & Other FM Symptoms

  [ 559 votes ]   [ Discuss This Article ]
By Editor • www.ProHealth.com • February 2, 2007


A Phase IV study at Robert Wood Johnson Medical School in Piscataway, New Jersey, is testing the sleep drug eszopiclone (Lunesta®) for the treatment of insomnia and other symptoms of Fibromyalgia. The trial, sponsored by Sepracor, Inc., is recruiting Fibromyalgia patients of both sexes between the ages of 18 and 64.

Study Purpose and Hypothesis
“Although the pathophysiology of FM is not yet well-understood, sleep disturbance is a prominent feature of most theories. Eszopiclone has been approved by the FDA for the treatment of insomnia, but has not been studied in the treatment of FMS. The purpose is to assess the efficacy of eszopiclone for the treatment of insomnia and other symptoms of Fibromyalgia (FMS) in FMS patients. Participants will be randomly selected to receive eszopiclone or placebo. It is hypothesized that participants receiving eszopiclone will report greater improvement in total sleep time, sleep quality, pain, fatigue, physical functioning, and emotional distress than will those receiving placebo (fake dose).

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: “Eszopiclone in the Treatment of Insomnia and Associated Symptoms of Fibromyalgia” (ClinicalTrials.com number NCT00392041)

Primary Outcome to Be Measured
n Total sleep time (TST) as recorded in patient diaries

Secondary Outcomes to Be Measured
n Wake time after sleep onset (WASO)
n Sleep quality
n Clinician-rated overall severity of Fibromyalgia
n Fibromyalgia Impact Questionnaire

Requirements for Inclusion:
n Male or female, age 18 through 64.
n Meets ACR criteria for FMS, as determined by rheumatological examination and a medical history review.
n Reports sleep maintenance insomnia (total sleep time of < 6.5 hours or sleep impairment consisting of 3 of 7 nights per week for a month by history) or sleep onset latency insomnia (at least 3 of 7 nights of sleep latency > 30 minutes), as well as clinically significant daytime distress or impairment during the 1 week self assessment prior to baseline.
n Has completed 8th grade and is fluent in English.
n If a female of child bearing potential, the patient must be non-pregnant and either post-menopausal or using an approved birth control method. Acceptable birth control methods include: history of tubal ligation, having a male partner who is sterile, IUDs, birth control pills or other hormonal birth control methods (e.g., birth control patch, Depo-Provera injections), and double-barrier methods (e.g., condom and foam).
n Antidepressant medication will be allowed if the patient has been on a stable dose for at least one month.

Exclusion Criteria:
n Evidence of traumatic injury, inflammatory rheumatic disease, or infectious or endocrine-related arthropathy.
n Evidence of a primary sleep disorder (e.g., significant sleep disordered breathing (central or obstructive apnea), periodic limb movement disorder, or REM sleep behavior disorder.
n Any current, clinically significant medical condition.
n Pregnancy.
n Meets DSM-IV criteria for bipolar disorder, psychotic disorder, organic brain syndrome, or psychoactive substance abuse or dependence.
n Any current psychiatric disorder that would interfere with study participation (investigator judgment).
n Active suicidal ideation.
n Plans to engage in additional psychotherapy during the study.
n Concurrent use of benzodiazepines after 6pm or as a sleep aid.
n Concurrent use of any other sleep aid.
n Concurrent use of analgesics other than acetaminophen or non-steroidal anti-inflammatory medication.
n Concurrent use of any medication that has not been stabilized for at least 1 month prior to screening.

Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00392041

Department of Psychiatry, University of Medicine and Dentistry New Jersey
(UMDNJ)-Robert Wood Johnson Medical School, Piscataway, New Jersey

Prinical Investigator Lesley A. Allen, PhD 732-235-4412
allenla@umdnj.edu Jade Tiu, B.A. 732-235-3378
tiuje@umdnj.edu

Health Authority: United States Institutional Review Board




Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor® Ultra EPA  - Fish Oil

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS, Fibromyalgia & Lyme Disease treatment and research news
 Privacy Guaranteed  |  View Archives

How Glutathione Can Save Your Life

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel
The Fast-Acting Solution for Healthy Digestive Function The Fast-Acting Solution for Healthy Digestive Function
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
Safely Burn Away Body Fat Safely Burn Away Body Fat
Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?

FIBROMYALGIA
What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Causes
Fibromyalgia Treatments
Fibromyalgia Diet
Fibromyalgia Medications
M.E. & CFS
What is M.E./CFS?
M.E./CFS Diagnosis
M.E./CFS Symptoms
M.E./CFS Causes
M.E./CFS Treatments
M.E./CFS Diet
M.E./CFS Medications
LYME DISEASE
What is Lyme Disease?
Lyme Disease Diagnosis
Lyme Disease Symptoms
Lyme Disease Causes
Lyme Disease Treatments
Lyme Disease Diet
Lyme Disease Medications
FORUMS
Fibromyalgia
M.E. & CFS
Lyme Disease
General Health
WHOLESALE
AFFILIATES GUARANTEE
PRIVACY
CONTACT US
LIBRARY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing